Christopher Galletta

Insider Reports History

Location
New Haven, CT
Signature
/s/ Christopher Galletta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Galletta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Controller and Principal Accounting Officer Common Stock 26,095 $13,334 $0.5110 02 Dec 2025 Direct
Trevi Therapeutics, Inc. Controller and Principal Accounting Officer Stock Option (right to buy) 35,000 19 Feb 2026 Direct
Trevi Therapeutics, Inc. Controller and Principal Accounting Officer Performance Stock Option (right to buy) 13,110 31 May 2025 Direct

Insider Reports Filed by Christopher Galletta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRVI Trevi Therapeutics, Inc. 19 Feb 2026 1 $0 4 Controller and Principal Accounting Officer 20 Feb 2026, 16:16
TRVI Trevi Therapeutics, Inc. 02 Dec 2025 2 +$2,159 4 Controller and Principal Accounting Officer 03 Dec 2025, 16:16
TRVI Trevi Therapeutics, Inc. 31 May 2025 1 $0 4 Controller and Principal Accounting Officer 03 Jun 2025, 16:00
TRVI Trevi Therapeutics, Inc. 10 Mar 2025 1 $0 4 Controller and Principal Accounting Officer 12 Mar 2025, 16:00
TRVI Trevi Therapeutics, Inc. 18 Feb 2025 1 $0 4 Controller and Principal Accounting Officer 20 Feb 2025, 16:00
TRVI Trevi Therapeutics, Inc. 13 Dec 2024 2 +$7,665 4 Controller and Principal Accounting Officer 17 Dec 2024, 16:30
TRVI Trevi Therapeutics, Inc. 15 Feb 2024 1 $0 4 Controller and Principal Accounting Officer 16 Feb 2024, 16:44
TRVI Trevi Therapeutics, Inc. 16 Feb 2023 1 $0 4 Controller and Principal Accounting Officer 16 Feb 2023, 16:34
TRVI Trevi Therapeutics, Inc. 11 Feb 2022 1 $0 4 Controller and Principal Accounting Officer 15 Feb 2022, 15:00